TEVA PHARMACEUTICAL INDUSTRIES LIMITED Inventory Recall Expense
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported Inventory Recall Expense of $54.00 million for the 12-month period ending 2019-12-31, per its 10-Q filed 2020-05-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InventoryRecallExpense · last filed 2020-05-07
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED inventory recall expense for the quarter ending 2019-12-31 was -$1.00M, a 120.00% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED inventory recall expense for the quarter ending 2019-09-30 was $0.00.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED inventory recall expense for the quarter ending 2019-06-30 was $4.00M, a 90.24% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED inventory recall expense for the quarter ending 2019-03-31 was $51.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED inventory recall expense for fiscal 2018 was $51.00M.
| Period end | Inventory Recall Expense 3 month | Inventory Recall Expense 6 month | Inventory Recall Expense 9 month | Inventory Recall Expense 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$1.00M derived: 10-Q 12 month − 10-Q 9 month · filed 2020-05-07 | -$1.00M derived: sum of 2 quarters · filed 2020-05-07 | $3.00M derived: sum of 3 quarters · filed 2020-05-07 | $54.00M 10-Q · filed 2020-05-07 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $4.00M derived: sum of 2 quarters · filed 2019-11-07 | $55.00M 10-Q · filed 2019-11-07 | $60.00M derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-06-30 | $4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $55.00M 10-Q · filed 2019-08-07 | $60.00M derived: sum of 3 quarters · filed 2019-08-07 | |
| 2019-03-31 | $51.00M 10-Q · filed 2019-05-02 | $56.00M derived: sum of 2 quarters · filed 2019-05-02 | ||
| 2018-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $51.00M 10-K · filed 2019-02-19 | ||
| 2018-09-30 | $46.00M 10-Q · filed 2018-11-01 | |||
| 2018-06-30 | $41.00M 10-Q · filed 2018-08-02 |